|
TFAP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.45839999999987E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.759910E-03 |
| Normal-vs-Stage2 |
4.895500E-03 |
| Normal-vs-Stage3 |
1.73124999999219E-05 |
| Normal-vs-Stage4 |
1.89583999999909E-05 |
| Stage1-vs-Stage2 |
4.578800E-01 |
| Stage1-vs-Stage3 |
3.183400E-03 |
| Stage1-vs-Stage4 |
1.284040E-03 |
| Stage2-vs-Stage3 |
5.828400E-02 |
| Stage2-vs-Stage4 |
3.870300E-02 |
| Stage3-vs-Stage4 |
7.500200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.976930E-04 |
| Normal-vs-AfricanAmerican |
6.239100E-04 |
| Normal-vs-Asian |
4.139900E-02 |
| Caucasian-vs-AfricanAmerican |
9.271000E-01 |
| Caucasian-vs-Asian |
8.998000E-01 |
| AfricanAmerican-vs-Asian |
9.258000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.185840E-04 |
| Normal-vs-Female |
4.07159999999962E-05 |
| Male-vs-Female |
2.615200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.320100E-03 |
| Normal-vs-Extreme_Weight |
5.810200E-04 |
| Normal-vs-Obese |
4.13970000000541E-05 |
| Normal-vs-Extreme_Obese |
5.969900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.704800E-01 |
| Normal_Weight-vs-Obese |
3.925000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.218000E-01 |
| Extreme_Weight-vs-Obese |
2.134800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.665800E-01 |
| Obese-vs-Extreme_Obese |
4.879400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.996470E-03 |
| Normal-vs-Age(41-60Yrs) |
2.20569999999087E-05 |
| Normal-vs-Age(61-80Yrs) |
6.165600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.882800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.179020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.717600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.617500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.561600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.095700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.703700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.12539999999706E-05 |
| Normal-VS-Type2 PRCC |
2.520000E-02 |
| Normal-VS-KIRP CIMP |
5.482700E-03 |
| Normal-VS-Unclassified PRCC |
1.976510E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.078500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.406400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.631400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.186000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.417900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.266400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.401400E-03 |
| Normal-vs-N1 |
4.76920000158643E-08 |
| Normal-vs-N2 |
2.755300E-03 |
| N0-vs-N1 |
2.48929999999703E-05 |
| N0-vs-N2 |
7.464300E-02 |
| N1-vs-N2 |
6.506800E-01 |
|
|
